The effect of Montelukast in the treatment of cystitis
Phase 3
- Conditions
- Cystitis.Cystitis
- Registration Number
- IRCT20220203053919N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
age 5 to 15 years
clinical diagnosis of cystitis
History of allergy
Exclusion Criteria
Fever
Any complications associated with the disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical symptoms of cystitis. Timepoint: From the beginning of the intervention on a daily basis for 10 days. Method of measurement: Biography.
- Secondary Outcome Measures
Name Time Method